We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Viral Outgrowth Assay Developed for Latent HIV

By LabMedica International staff writers
Posted on 14 Jun 2013
The development of a simpler assay for the latent reservoir of human immunodeficiency virus (HIV) has been identified as a major priority in the study of acquired immunodeficiency syndrome (AIDS). More...


A rapid viral outgrowth assay that quantifies the frequency of cells that can release replication-competent virus following cellular activation has been developed and validated using a novel quantitative molecular technique.

Scientists at Johns Hopkins University School of Medicine (Baltimore, MD, USA) enrolled 20 HIV-1 infected patients in a study and peripheral blood mononuclear cells (PBMC) were isolated using density gradient centrifugation. CD4+ T lymphocytes were enriched by negative depletion. For each patient, both a standard viral outgrowth assay and a MOLT-4/CCR5 viral outgrowth assay were performed using freshly purified resting CD4+ T lymphocytes obtained from a single blood draw. Resting CD4+ T lymphocytes were further enriched through negative depletion of cells using specific microbeads (Miltenyi Biotec; Auburn, CA, USA).

Complementary DNA (cDNA) was synthesized from the isolated HIV-1 RNA using the SuperScript III First-Strand Synthesis System (Invitrogen, Grand Island, NY, USA) with oligo-dT primers. The assay employs a novel quantitative reverse transcription polymerase chain reaction (RT-PCR) specific for polyadenylated HIV-1 RNA for virus detection, which is a more sensitive and cost-effective method to detect HIV-1 replication than expensive commercial enzyme-linked immunosorbent assay (ELISA) detection methods.

On average, viral outgrowth from the latent reservoir under conditions resembling the MOLT-4/CCR5 viral outgrowth assay was detectable by the HIV-1 specific RT-PCR assay after six days versus 10 days for HIV-1 p24 antigen ELISA. There was no significant difference between the frequency of latent infection of resting CD4+ T cells as measured at day seven using HIV-1 specific RT-PCR and at day 14 as measured by HIV-1 p24 antigen ELISA. The utilization of an RT-PCR based measurement for HIV-1 outgrowth not only allows more sensitive detection of viral replication but also will allow higher throughput measurement of HIV-1 replication.

The authors concluded that the MOLT-4/CCR5 utilizing viral outgrowth assay is the most rapid and scalable assay available for measuring the size of the HIV-1 latent reservoir. As such, they believe that this assay will be an indispensable tool in evaluating the success of strategies to curtail or eradicate the HIV-1 latent reservoir. The study was published on May 30, 2013, in the journal Public Library of Science Pathogens.


Related Links:

Johns Hopkins University School of Medicine

Miltenyi Biotec
Invitrogen


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.